Sensitivity and Depth Penetration of Continuous Wave Versus Frequency-domain Photon Migration Near-infrared Fluorescence Contrast–enhanced Imaging¶

Abstract The development of near-infrared fluorescent contrast agents and imaging techniques depends on the deep penetration of excitation light through several centimeters of tissue and the sensitive collection of the re-emitted fluorescence. In this contribution, the sensitivity and depth penetration of various fluorescence-enhanced imaging studies is surveyed and compared with current studies using continuous wave (CW) and frequency-domain photon migration (FDPM) measurements with planar wave illumination of modulated excitation light at 100 MHz and area collection of reemitted fluorescent light using a previously developed modulated intensified charge-coupled device camera system. Fluorescence was generated from nanomolar to micromolar solutions of indocyanine green (ICG) in a 100 μL volume submerged at 1–4 cm depths in a 1% Liposyn® solution to mimic tissue scattering properties. Enhanced depth penetration and sensitivity are achieved with optimal filter rejection of excitation light, and FDPM rejection of background light is not achieved using CW methods. We show the ability to detect as few as 100 fmol of ICG from area illumination of 785 nm light (5.5 mW/cm2) and FDPM area collection of 830 nm fluorescent light generated from 3 cm below the phantom surface. The lowered noise floor of FDPM measurements enables greater sensitivity and penetration depth than comparable CW measurements.

[1]  R W McClane,et al.  APPLICATION OF CHARGE‐COUPLED DEVICE TECHNOLOGY FOR MEASUREMENT OF LASER LIGHT AND FLUORESCENCE DISTRIBUTION IN TUMORS FOR PHOTODYNAMIC THERAPY , 1991, Photochemistry and photobiology.

[2]  Eva M Sevick-Muraca,et al.  Near-infrared fluorescence contrast-enhanced imaging with area illumination and area detection: the forward imaging problem. , 2003, Applied optics.

[3]  K. Kern,et al.  Preoperative lymphoscintigraphy during lymphatic mapping for breast cancer: improved sentinel node imaging using subareolar injection of technetium 99m sulfur colloid. , 2000, Journal of the American College of Surgeons.

[4]  R Cubeddu,et al.  TIME‐GATED FLUORESCENCE IMAGING FOR THE DIAGNOSIS OF TUMORS IN A MURINE MODEL , 1993, Photochemistry and photobiology.

[5]  Daniel J. Hawrysz,et al.  Three-dimensional, Bayesian image reconstruction from sparse and noisy data sets: Near-infrared fluorescence tomography , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Wolfhard Semmler,et al.  Transferrin-mediated tumor delivery of contrast media for optical imaging and magnetic resonance imaging , 1999, Photonics West - Biomedical Optics.

[7]  Eva M. Sevick-Muraca,et al.  Multipixel assessment of fluorescence uptake and lifetime in the detection of heterogeneous tissue volumes , 1999, Photonics West - Biomedical Optics.

[8]  P. V. van Diest,et al.  Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. , 1998, Journal of the American College of Surgeons.

[9]  V. Ntziachristos,et al.  Hydrophilic Cyanine Dyes as Contrast Agents for Near-infrared Tumor Imaging: Synthesis, Photophysical Properties and Spectroscopic In vivo Characterization¶ , 2000, Photochemistry and photobiology.

[10]  R Weissleder,et al.  Near-infrared optical imaging of protease activity for tumor detection. , 1999, Radiology.

[11]  K. Sakatani,et al.  Noninvasive optical imaging of the subarachnoid space and cerebrospinal fluid pathways based on near-infrared fluorescence. , 1997, Journal of neurosurgery.

[12]  Eva M Sevick-Muraca,et al.  Three-dimensional fluorescence enhanced optical tomography using referenced frequency-domain photon migration measurements at emission and excitation wavelengths. , 2002, Journal of the Optical Society of America. A, Optics, image science, and vision.

[13]  Serge R. Mordon,et al.  Effect of indocyanin green formulation on blood clearance and in vivo fluorescence kinetic profile of skin , 1995, European Conference on Biomedical Optics.

[14]  Robert E. Lenkinski,et al.  In vivo near-infrared fluorescence imaging of osteoblastic activity , 2001, Nature Biotechnology.

[15]  Dario Neri,et al.  Targeting by affinity–matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform , 1997, Nature Biotechnology.

[16]  R Cubeddu,et al.  Fluorescence Lifetime Imaging of Experimental Tumors in Hematoporphyrin Derivative‐Sensitized Mice , 1997, Photochemistry and photobiology.

[17]  S. Achilefu,et al.  Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging. , 2000, Investigative radiology.

[18]  Eva M Sevick-Muraca,et al.  Near-infrared fluorescence contrast-enhanced imaging with intensified charge-coupled device homodyne detection: measurement precision and accuracy. , 2003, Journal of biomedical optics.

[19]  S. Achilefu,et al.  Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor-targeted dye-peptide conjugate platform. , 2001, Journal of biomedical optics.

[20]  Uwe Sukowski,et al.  Imaging of superficially growing tumors by delayed observation of laser-induced fluorescence , 1993, Photonics West - Lasers and Applications in Science and Engineering.

[21]  Henry H. Mantsch,et al.  In vivo monitoring of the distribution of a monoclonal antibody fragment , 2002 .

[22]  Raghavan Rajagopalan,et al.  New approach to optical imaging of tumors , 2001, SPIE BiOS.

[23]  Samuel Achilefu,et al.  Synthesis, in vitro receptor binding, and in vivo evaluation of fluorescein and carbocyanine peptide-based optical contrast agents. , 2002, Journal of medicinal chemistry.

[24]  H. van den Bergh,et al.  Antibody–fluorescein conjugates for photoimmunodiagnosis of human colon carcinoma in nude mice , 1991, Cancer.

[25]  M M Haglund,et al.  Enhanced optical imaging of rat gliomas and tumor margins. , 1994, Neurosurgery.

[26]  W. Semmler,et al.  Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands , 2001, Nature Biotechnology.

[27]  Eva M. Sevick-Muraca,et al.  Pharmacokinetics of ICG and HPPH-car for the Detection of Normal and Tumor Tissue Using Fluorescence, Near-infrared Reflectance Imaging: A Case Study¶ , 2000, Photochemistry and photobiology.

[28]  J Lee,et al.  Error consideration in contrast-enhanced three-dimensional optical tomography. , 2001, Optics letters.

[29]  Wolfhard Semmler,et al.  Macromolecular Contrast Agents for Optical Imaging of Tumors: Comparison of Indotricarbocyanine-labeled Human Serum Albumin and Transferrin¶ , 2000, Photochemistry and photobiology.

[30]  J. S. Reynolds,et al.  Imaging of Spontaneous Canine Mammary Tumors Using Fluorescent Contrast Agents , 1999, Photochemistry and photobiology.

[31]  Stefan Andersson-Engels,et al.  Optical detection of human urinary bladder carcinoma utilising tissue autoflurescence and protoporphyrin IX-induced fluorescence following low dose ALA instillation , 1995, European Conference on Biomedical Optics.

[32]  C. Heusser,et al.  Immunophotodiagnosis of colon carcinomas in patients injected with fluoresceinated chimeric antibodies against carcinoembryonic antigen. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Kennedy,et al.  A COMPARISON OF FLUORESCENCE METHODS USED IN THE PHARMACOKINETIC STUDIES OF Zn(II)PHTHALOCYANINE IN MICE , 1991, Photochemistry and photobiology.

[34]  R. Weissleder,et al.  In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.

[35]  H. Cody,et al.  Sentinel lymph node biopsy in breast cancer: unfiltered radioisotope is superior to filtered. , 1999, Journal of the American College of Surgeons.

[36]  D L Farkas,et al.  Cyanine fluorochrome-labeled antibodies in vivo: assessment of tumor imaging using Cy3, Cy5, Cy5.5, and Cy7. , 1998, Cancer detection and prevention.

[37]  M M Haglund,et al.  Enhanced optical imaging of human gliomas and tumor margins. , 1996, Neurosurgery.

[38]  J. S. Reynolds,et al.  Multipixel Techniques for Frequency‐Domain Photon Migration Imaging , 1997, Biotechnology progress.

[39]  H. Bergh,et al.  Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice. , 1994, Cancer research.

[40]  C. L. Hutchinson,et al.  Fluorescence and Absorption Contrast Mechanisms for Biomedical Optical Imaging Using Frequency‐Domain Techniques , 1997, Photochemistry and photobiology.

[41]  Raghavan Rajagopalan,et al.  Site-specific tumor-targeted fluorescent contrast agents , 2001, European Conference on Biomedical Optics.

[42]  W. Semmler,et al.  Near-infrared fluorescent dyes for enhanced contrast in optical mammography: phantom experiments. , 2001, Journal of biomedical optics.

[43]  R. Weissleder,et al.  Experimental three-dimensional fluorescence reconstruction of diffuse media by use of a normalized Born approximation. , 2001, Optics letters.

[44]  Ralph Weissleder,et al.  In vivo molecular target assessment of matrix metalloproteinase inhibition , 2001, Nature Medicine.

[45]  E. Hull,et al.  Porphyrin Bleaching and PDT-induced Spectral Changes are Irradiance Dependent in ALA-sensitized Normal Rat Skin In Vivo¶ , 2001, Photochemistry and photobiology.

[46]  Huabei Jiang,et al.  Frequency-domain fluorescent diffusion tomography of turbid media and in-vivo tissues , 2001, SPIE BiOS.

[47]  Michael R Hamblin,et al.  Epidermal growth factor receptor-targeted immunophotodiagnosis and photoimmunotherapy of oral precancer in vivo. , 2001, Cancer research.

[48]  Albert Cerussi,et al.  Noninvasive functional optical spectroscopy of human breast tissue , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Daniel L. Farkas,et al.  Tumor labeling in vivo using cyanine-conjugated monoclonal antibodies , 1995, Cancer Immunology, Immunotherapy.

[50]  K Svanberg,et al.  Clinical spectral characterisation of colonic mucosal lesions using autofluorescence and δ aminolevulinic acid sensitisation , 1999, Gut.